Compare YDES & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | YDES | ROMA |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | Taiwan | Hong Kong |
| Employees | N/A | N/A |
| Industry | | Savings Institutions |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.0M | 542.0M |
| IPO Year | 2024 | 2022 |
| Metric | YDES | ROMA |
|---|---|---|
| Price | $4.22 | $8.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 174.8K | 3.5K |
| Earning Date | 05-12-2026 | 12-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.70 | $1.16 |
| 52 Week High | $25.00 | $11.77 |
| Indicator | YDES | ROMA |
|---|---|---|
| Relative Strength Index (RSI) | 59.28 | 50.04 |
| Support Level | $1.99 | $8.01 |
| Resistance Level | $5.15 | $9.75 |
| Average True Range (ATR) | 0.84 | 0.40 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 59.17 | 47.71 |
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
Roma Green Finance Ltd is a professional specialist in the provision of environmental, social and governance (ESG), sustainability and climate change related advisory services through its operating subsidiaries in Hong Kong and Singapore. Its services include Sustainability Program Development, ESG Reporting, Corporate Governance and Risk Management, Climate Change Strategies and Solutions, Environmental Audit, ESG Rating Support and Shareholder Communication, and Education and Training. It operates in one reporting business segment in Hong Kong and Singapore, of which the majority of revenue is derived from Hong Kong.